User profiles for "author:Faheez Mohamed"

Faheez Mohamed

Consultant Surgeon, North Hampshire Hospital, Basingstoke
Verified email at nhs.net
Cited by 8100

Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia

O Glehen, F Mohamed, FN Gilly - The lancet oncology, 2004 - thelancet.com
Peritoneal carcinomatosis is a common manifestation of digestive-tract cancer and has been
regarded a terminal disease with a short median survival. Over the past decade, a new …

A review of peritoneal mesothelioma at the Washington Cancer Institute

PH Sugarbaker, LS Welch… - Surgical Oncology …, 2003 - surgonc.theclinics.com
Peritoneal mesothelioma is an unusual disease that diffusely involves the peritoneal
surfaces. The incidence of both pleural and peritoneal mesothelioma has been rising …

Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases

NJ Carr, J Finch, IC Ilesley… - Journal of clinical …, 2012 - jcp.bmj.com
Aims The classification of abdominal mucinous neoplasia is a controversial area. In 2010,
WHO published a classification which divides pseudomyxoma peritonei (PMP) into low and …

[PDF][PDF] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience

TD Yan, M Deraco, D Baratti, S Kusamura… - Journal of Clinical …, 2009 - researchgate.net
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant
Peritoneal Mesothelioma: Multi-Institutional E Page 1 Cytoreductive Surgery and Hyperthermic …

A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal neoplasia: the results of the Peritoneal Surface …

NJ Carr, TD Cecil, F Mohamed, LH Sobin… - The American journal …, 2016 - journals.lww.com
Pseudomyxoma peritonei (PMP) is a complex disease with unique biological behavior that
usually arises from appendiceal mucinous neoplasia. The classification of PMP and its …

Thermal enhancement of new chemotherapeutic agents at moderate hyperthermia

F Mohamed, P Marchettini, OA Stuart, M Urano… - Annals of surgical …, 2003 - Springer
Background: Hyperthermia enhances the cytotoxicity of some chemotherapeutic agents. We
have studied the effect of moderate hyperthermia (41.5° C) on the cytotoxicity of five new …

Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin

H Youssef, C Newman… - Diseases of the colon …, 2011 - journals.lww.com
BACKGROUND: Pseudomyxoma peritonei syndrome is a clinical entity characterized by
mucinous ascites usually originating from a perforated mucinous appendiceal tumor …

Cytoreductive surgery and intraperitoneal chemohyperthermia for chemoresistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patients

E Cotte, O Glehen, F Mohamed, F Lamy… - World journal of …, 2007 - Wiley Online Library
Purpose There is no standardized treatment for patients with chemoresistant or recurrent
advanced ovarian cancer. Locoregional treatments combining cytoreductive surgery and …

Appendiceal tumours and pseudomyxoma peritonei: literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment

K Govaerts, RJ Lurvink, I De Hingh… - European Journal of …, 2021 - Elsevier
Pseudomyxoma Peritonei (PMP) is a rare peritoneal malignancy, most commonly originating
from a perforated epithelial tumour of the appendix. Given its rarity, randomized controlled …

[HTML][HTML] Pseudomyxoma peritonei

KE Bevan, F Mohamed, BJ Moran - World journal of …, 2010 - ncbi.nlm.nih.gov
Pseudomyxoma peritonei (PMP) is an uncommon “borderline malignancy” generally arising
from a perforated appendiceal epithelial tumour. Optimal treatment involves a combination …